20 June 2013
Keywords: ceragenix, enters, mrsa, bird, flu, accord, usa
Article | 03 July 2006
The USA's Ceragenix Pharmaceuticals has entered into an R&D agreement with an internationally-recognized undisclosed research laboratory to
develop formulations, ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
There are no related articles.
19 June 2013
© 2013 thepharmaletter.com